Article details
Future Vision for Health Training Co. announced a cooperation agreement with the Saudi Charitable Association of Diabetes (SCAD) to organize the 11th Diabetes and Quality of Life Conference 2026. The contract value exceeds 5% of the company’s 2025 audited revenue, estimated at SAR 896,500 based on its SAR 17.93 million annual revenue. The agreement, signed on July 4, is non-related party and valid for one year, with financial impacts expected to appear in Q1 2027 results.
This contract represents a significant revenue stream for Future Vision, potentially boosting its earnings in 2027. Investors may view this as a positive sign of the company’s ability to secure large-scale contracts in the healthcare training sector. However, the long-term financial impact depends on the conference’s execution and future follow-up contracts. Traders should monitor Future Vision’s Q1 2027 earnings reports for confirmation of the deal’s contribution.
For Saudi equity markets, this deal highlights the company’s strategic focus on expanding its healthcare training portfolio. The agreement aligns with Saudi Arabia’s Vision 2030 initiatives to strengthen healthcare infrastructure. MENA investors should watch for any follow-on contracts or partnerships that could further diversify Future Vision’s revenue streams.
